-
Je něco špatně v tomto záznamu ?
Injectable nano-in situ-thermosensitive-hydrogels based on halofuginone and silver for postoperative treatment against triple-negative breast cancer
R. Zuo, J. Gong, X. Gao, E. Nepovimova, J. Zhang, S. Jiang, K. Kuca, W. Wu, D. Guo
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články
- MeSH
- chinazolinony * chemie aplikace a dávkování farmakologie MeSH
- hydrogely * aplikace a dávkování chemie MeSH
- kovové nanočástice aplikace a dávkování chemie MeSH
- lidé MeSH
- myši inbrední BALB C MeSH
- myši nahé MeSH
- myši MeSH
- nádorové buněčné linie MeSH
- patologická angiogeneze farmakoterapie MeSH
- piperidiny * farmakologie aplikace a dávkování chemie MeSH
- pohyb buněk účinky léků MeSH
- proliferace buněk * účinky léků MeSH
- protinádorové látky * aplikace a dávkování farmakologie chemie MeSH
- stříbro * chemie aplikace a dávkování MeSH
- triple-negativní karcinom prsu * farmakoterapie MeSH
- xenogenní modely - testy protinádorové aktivity MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- myši MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
Postoperative distant metastasis and high recurrence rate causes a dilemma in treating triple-negative breast cancer (TNBC) owing to its unforeseeable invasion into various organs or tissues. The wealth of nutrition provided by vascular may facilitate the proliferation and angiogenesis of cancer cells, which further enhance the rates of postoperative metastasis and recurrence. Chemotherapy, as a systemic postoperative adjuvant therapy, is generally applied to diminish recurrence and metastasis of TNBC. Herein, an halofuginone-silver nano thermosensitive hydrogel (HTPM&AgNPs-gel) was prepared via a physical swelling method. The in vitro anticancer efficacy of HTPM&AgNPs-gel was analyzed by investigating cell proliferation, migration, invasion, and angiogenesis capacity. Furthermore, the in vivo anti-cancer activity of HTPM&AgNPs-gel was further appraised through the tumor suppression, anti-metastatic, anti-angiogenic, and anti-inflammatory ability. The optimized HTPM&AgNPs-gel, a thermosensitive hydrogel, showed excellent properties, including syringeability, swelling behavior, and a sustained release effect without hemolysis. In addition, HTPM&AgNPs-gel was confirmed to effectively inhibit the proliferation, migration, invasion, and angiogenesis of MDA-MB-231 cells. An evaluation of the in vivo anti-tumor efficacy demonstrated that HTPM&AgNPs-gel showed a stronger tumor inhibition rate (68.17%) than did HTPM-gel or AgNPs-gel used alone and exhibited outstanding biocompatibility. Notably, HTPM&AgNPs-gel also inhibited lung metastasis induced by residual tumor tissue after surgery and further blocked angiogenesis-related inflammatory responses. Taken together, the suppression of inflammation by interdicting the blood vessels adjoining the tumor and inhibiting angiogenesis is a potential strategy to attenuate the recurrence and metastasis of TNBC. HTPM&AgNPs-gel is a promising anticancer agent for TNBC as a local postoperative treatment.
Biomedical Research Center University Hospital Hradec Kralove 50003 Hradec Kralove Czech Republic
School of Food and Biological Engineering Hefei University of Technology Hefei 230009 PR China
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24019332
- 003
- CZ-PrNML
- 005
- 20241024111450.0
- 007
- ta
- 008
- 241015e20240623ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ijpharm.2024.124384 $2 doi
- 035 __
- $a (PubMed)38917957
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Zuo, Runan $u Animal-Derived Food Safety Innovation Team, College of Animal Science and Technology, Anhui Province Key Lab of Veterinary Pathobiology and Disease Control, Anhui Agricultural University, Hefei, Anhui 230036, PR China; Engineering Center of Innovative Veterinary Drugs, Center for Veterinary Drug Research and Evaluation, MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, 1 Weigang, Nanjing 210095, PR China
- 245 10
- $a Injectable nano-in situ-thermosensitive-hydrogels based on halofuginone and silver for postoperative treatment against triple-negative breast cancer / $c R. Zuo, J. Gong, X. Gao, E. Nepovimova, J. Zhang, S. Jiang, K. Kuca, W. Wu, D. Guo
- 520 9_
- $a Postoperative distant metastasis and high recurrence rate causes a dilemma in treating triple-negative breast cancer (TNBC) owing to its unforeseeable invasion into various organs or tissues. The wealth of nutrition provided by vascular may facilitate the proliferation and angiogenesis of cancer cells, which further enhance the rates of postoperative metastasis and recurrence. Chemotherapy, as a systemic postoperative adjuvant therapy, is generally applied to diminish recurrence and metastasis of TNBC. Herein, an halofuginone-silver nano thermosensitive hydrogel (HTPM&AgNPs-gel) was prepared via a physical swelling method. The in vitro anticancer efficacy of HTPM&AgNPs-gel was analyzed by investigating cell proliferation, migration, invasion, and angiogenesis capacity. Furthermore, the in vivo anti-cancer activity of HTPM&AgNPs-gel was further appraised through the tumor suppression, anti-metastatic, anti-angiogenic, and anti-inflammatory ability. The optimized HTPM&AgNPs-gel, a thermosensitive hydrogel, showed excellent properties, including syringeability, swelling behavior, and a sustained release effect without hemolysis. In addition, HTPM&AgNPs-gel was confirmed to effectively inhibit the proliferation, migration, invasion, and angiogenesis of MDA-MB-231 cells. An evaluation of the in vivo anti-tumor efficacy demonstrated that HTPM&AgNPs-gel showed a stronger tumor inhibition rate (68.17%) than did HTPM-gel or AgNPs-gel used alone and exhibited outstanding biocompatibility. Notably, HTPM&AgNPs-gel also inhibited lung metastasis induced by residual tumor tissue after surgery and further blocked angiogenesis-related inflammatory responses. Taken together, the suppression of inflammation by interdicting the blood vessels adjoining the tumor and inhibiting angiogenesis is a potential strategy to attenuate the recurrence and metastasis of TNBC. HTPM&AgNPs-gel is a promising anticancer agent for TNBC as a local postoperative treatment.
- 650 12
- $a triple-negativní karcinom prsu $x farmakoterapie $7 D064726
- 650 12
- $a hydrogely $x aplikace a dávkování $x chemie $7 D020100
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 12
- $a stříbro $x chemie $x aplikace a dávkování $7 D012834
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 12
- $a piperidiny $x farmakologie $x aplikace a dávkování $x chemie $7 D010880
- 650 12
- $a proliferace buněk $x účinky léků $7 D049109
- 650 12
- $a chinazolinony $x chemie $x aplikace a dávkování $x farmakologie $7 D052999
- 650 12
- $a protinádorové látky $x aplikace a dávkování $x farmakologie $x chemie $7 D000970
- 650 _2
- $a myši inbrední BALB C $7 D008807
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a pohyb buněk $x účinky léků $7 D002465
- 650 _2
- $a kovové nanočástice $x aplikace a dávkování $x chemie $7 D053768
- 650 _2
- $a patologická angiogeneze $x farmakoterapie $7 D009389
- 650 _2
- $a xenogenní modely - testy protinádorové aktivity $7 D023041
- 650 _2
- $a myši nahé $7 D008819
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Gong, Jiahao $u Engineering Center of Innovative Veterinary Drugs, Center for Veterinary Drug Research and Evaluation, MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, 1 Weigang, Nanjing 210095, PR China
- 700 1_
- $a Gao, Xiuge $u Engineering Center of Innovative Veterinary Drugs, Center for Veterinary Drug Research and Evaluation, MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, 1 Weigang, Nanjing 210095, PR China
- 700 1_
- $a Nepovimova, Eugenie $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Kralove, Czech Republic
- 700 1_
- $a Zhang, Junren $u Engineering Center of Innovative Veterinary Drugs, Center for Veterinary Drug Research and Evaluation, MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, 1 Weigang, Nanjing 210095, PR China
- 700 1_
- $a Jiang, Shanxiang $u Engineering Center of Innovative Veterinary Drugs, Center for Veterinary Drug Research and Evaluation, MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, 1 Weigang, Nanjing 210095, PR China
- 700 1_
- $a Kuca, Kamil $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Kralove, Czech Republic; Biomedical Research Center, University Hospital Hradec Kralove, 50003 Hradec Kralove, Czech Republic; Andalusian Research Institute in Data Science and Computational Intelligence (DaSCI), University of Granada, Granada, Spain. Electronic address: kamil.kuca@uhk.cz
- 700 1_
- $a Wu, Wenda $u School of Food and Biological Engineering, Hefei University of Technology, Hefei 230009, PR China. Electronic address: bzwh@163.com
- 700 1_
- $a Guo, Dawei $u Engineering Center of Innovative Veterinary Drugs, Center for Veterinary Drug Research and Evaluation, MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, 1 Weigang, Nanjing 210095, PR China. Electronic address: gdawei0123@njau.edu
- 773 0_
- $w MED00002359 $t International journal of pharmaceutics $x 1873-3476 $g Roč. 661 (20240623), s. 124384
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38917957 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20241015 $b ABA008
- 991 __
- $a 20241024111444 $b ABA008
- 999 __
- $a ok $b bmc $g 2201897 $s 1231305
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 661 $c - $d 124384 $e 20240623 $i 1873-3476 $m International journal of pharmaceutics $n Int J Pharm $x MED00002359
- LZP __
- $a Pubmed-20241015